Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT06248632
Eligibility Criteria:
Inclusion Criteria:
* Children and adults with genetically confirmed XLH followed at the Lyon Reference Centre for Rare Calcium, Phosphorus and Magnesium Diseases
* Patients treated with Burosumab
* Patients \>12 kg.
* Patients and parent/guardian who have been informed of the study and who do not object to participate
Exclusion Criteria:
* Patients undergoing treatment with oral corticosteroids, or who have received more than 3 months of corticosteroid therapy in the past.
* Patients who have received or are currently receiving immunosuppressive therapy.
* Patients suffering from an inflammatory disease
* Pregnant or breast-feeding women
* Persons deprived of their liberty by judicial or administrative decision
* Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
99 Years
Study:
NCT06248632
Study Brief:
Protocol Section:
NCT06248632